Correlation Between Milestone Pharmaceuticals and Molecular Templates
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Molecular Templates at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Molecular Templates into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Molecular Templates, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Molecular Templates and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Molecular Templates. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Molecular Templates.
Diversification Opportunities for Milestone Pharmaceuticals and Molecular Templates
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Molecular is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Molecular Templates in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Templates and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Molecular Templates. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Templates has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Molecular Templates go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Molecular Templates
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.2 times more return on investment than Molecular Templates. However, Milestone Pharmaceuticals is 5.01 times less risky than Molecular Templates. It trades about 0.3 of its potential returns per unit of risk. Molecular Templates is currently generating about 0.03 per unit of risk. If you would invest 143.00 in Milestone Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 44.00 from holding Milestone Pharmaceuticals or generate 30.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Molecular Templates
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Molecular Templates |
Milestone Pharmaceuticals and Molecular Templates Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Molecular Templates
The main advantage of trading using opposite Milestone Pharmaceuticals and Molecular Templates positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Molecular Templates can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Templates will offset losses from the drop in Molecular Templates' long position.The idea behind Milestone Pharmaceuticals and Molecular Templates pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Molecular Templates vs. Century Therapeutics | Molecular Templates vs. Kezar Life Sciences | Molecular Templates vs. Mineralys Therapeutics, Common | Molecular Templates vs. Nkarta Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |